CREDIT SUISSE AG/ - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3
-100.0%
1
-100.0%
0.00%
-100.0%
Q3 2022$617,000
+81.5%
16,680
-6.9%
0.00%
Q2 2022$340,000
-28.9%
17,922
+1.3%
0.00%
Q1 2022$478,000
+94.3%
17,696
+62.2%
0.00%
Q4 2021$246,000
+6.5%
10,907
+51.0%
0.00%
Q2 2021$231,000
-9.1%
7,223
+0.3%
0.00%
Q1 2021$254,000
-33.7%
7,204
-39.8%
0.00%
Q4 2020$383,000
+71.0%
11,975
+100.8%
0.00%
Q3 2020$224,000
-36.9%
5,963
-25.0%
0.00%
Q2 2020$355,0007,9470.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders